## **Core Concept**
The question tests the understanding of mechanisms of action of various drugs, specifically focusing on transcription inhibitors. Transcription is the process by which the information in a strand of DNA is copied into a new molecule of messenger RNA (mRNA). Transcription inhibitors are substances that interfere with this process, thereby preventing the synthesis of proteins.

## **Why the Correct Answer is Right**
Actinomycin D (also known as Dactinomycin) is a well-known transcription inhibitor. It works by intercalating into DNA and preventing the elongation of RNA chains by RNA polymerase. This action effectively blocks the transcription of DNA into RNA, which is a critical step in the synthesis of proteins. Actinomycin D is used in research and as an antineoplastic agent.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Rifampicin is actually a transcription inhibitor but it works by inhibiting bacterial RNA polymerase. However, in the context of the options provided and common classification, it might not be the best fit if compared to Actinomycin D's broad mechanism.
- **Option B:** This option seems to be missing a specific drug name but based on common pharmacological knowledge, if it refers to a drug that does not primarily act as a transcription inhibitor, it would be incorrect.
- **Option C:** This option is also missing a drug name but if it refers to any drug not primarily known for inhibiting transcription, it would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Actinomycin D is used in the treatment of certain cancers (like Wilms' tumor, rhabdomyosarcoma, and Ewing's sarcoma) and it acts by inhibiting transcription. Its use is limited due to its toxicity profile.

## **Correct Answer:** D. Actinomycin D.